Xiaowei Wu
9PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Feb 24, 2026
Targeting de novo pyrimidine synthesis confers vulnerability to copper-mediated ATR inactivation in PARP inhibitor-resistant ovarian cancer.Yabing Nan, Kunyu Wang, Menghan Hu
|Nov 24, 2025
IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer.Yabing Nan, Sophie O'keefe, Xiadi He
|May 08, 2024
Targetable leukaemia dependency on noncanonical PI3Kγ signalling.Qingyu Luo, Evangeline G Raulston, Miguel A Prado
|Dec 13, 2023
RUNX1-IT1 acts as a scaffold of STAT1 and NuRD complex to promote ROS-mediated NF-κB activation and ovarian cancer progression.Xiao Yu, Pengfei Zhao, Qingyu Luo
|Jun 22, 2022
DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma.Yabing Nan, Qingyu Luo, Xiaowei Wu
Pageof 2
Frequent Collaborators
8 joint publications
Qingyu Luo
6 joint publications
Zhihua Liu
4 joint publications
Yabing Nan
2 joint publications
Xiao Yu
2 joint publications
Zhumei Cui
2 joint publications
Christopher A G Booth
2 joint publications
Andrew A Lane
2 joint publications
John G Doench
1 joint publications
David E Root
1 joint publications
Aiping Zhou